FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Google | Prediction Models | Numerate

Google-like code aids drug development

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

A new generation of companies with more powerful computer technology is applying itself to the business of drug development. And among them is Numerate of San Bruno, CA.

Numerate uses Google-like code to develop drugs, says the San Francisco Business Times. The paper profiles several Bay Area companies that are using algorithms and cloud computing to sort through compounds "faster than ever before to design, create or redirect compounds, then decide whether to test the drugs in humans."

Numerate was recently awarded a patent for methods of using biological assay data to develop predictive models. The models, according to the company, boast accuracy comparable to that of lab testing.

Its approach involves a statistics-based method of discerning what compounds a company might pursue given the discovery and development data it already has. That strategy, says Numerate, contrasts with more traditional assumption-based methods that attempt to "simulate nature."

- see the article (subscription required)
- here's the patent release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about Google   Prediction Models   Numerate